MiniMed (MMEDV) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
- Closed at $17.70, +1.14% vs the prior close of $17.50.
- Volume 226.90K shares, 9.5x its 50-day average (heavy).
- New SEC filings: 4 (Oct 16, 2026), 4 (Oct 16, 2026), 4 (Oct 16, 2026), 3 (Oct 16, 2026), SCHEDULE 13G/A (Oct 16, 2026), 4 (Oct 16, 2026).
- No new insider buys or sales reported since the prior session.
MMEDV rises 1.1% to $17.70 on 10.9x normal volume. Closed at $17.70, +1.14% vs the prior close of $17.50. Day range $17.44–$18.35, opened at $18.20.
MMEDV daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — MMEDV rises 1.1% to $17.70 on 10.9x normal volume
- Closed at $17.70, +1.14% vs the prior close of $17.50. Day range $17.44–$18.35, opened at $18.20.
- Volume was 226.90K shares, 10.9x its 50-day average of 20.84K — unusually heavy trading.
- 52-week range $15.50–$21.50; today's close sits at 37% of that range, 17.7% below the 52-week high.
Oct 15, 2026 — MMEDV rises 2.2% to $17.50 on 6.1x normal volume
- Closed at $17.50, +2.16% vs the prior close of $17.13. Day range $17.20–$18.57, opened at $18.50.
- Volume was 77.80K shares, 6.1x its 50-day average of 12.70K — unusually heavy trading.
- 52-week range $15.50–$21.50; today's close sits at 33% of that range, 18.6% below the 52-week high.
Oct 14, 2026 — MMEDV slides 7.7% to $17.13, 4 down days in a row
- Closed at $17.13, -7.65% vs the prior close of $18.55. Day range $15.50–$18.52, opened at $18.52.
- Volume was 5.60K shares, 0.4x its 50-day average of 13.88K — lighter than usual.
- 52-week range $15.50–$21.50; today's close sits at 27% of that range, 20.3% below the 52-week high.
- That makes 4 straight losses.
Oct 13, 2026 — MMEDV dips 2.9% to $18.55, 3 down days in a row
- Closed at $18.55, -2.88% vs the prior close of $19.10. Day range $18.55–$21.50, opened at $21.12.
- Volume was 12.10K shares, 0.8x its 50-day average of 14.24K.
- 52-week range $18.50–$21.50; today's close sits at 2% of that range, 13.7% below the 52-week high.
- That makes 3 straight losses.
- SEC filings that day: 8-K.
Oct 12, 2026 — MMEDV dips 2.1% to $19.10 on 34.0x normal volume
- Closed at $19.10, -2.05% vs the prior close of $19.50. Day range $18.50–$19.43, opened at $18.50.
- Volume was 63.70K shares, 34.0x its 50-day average of 1.88K — unusually heavy trading.
- 52-week range $18.50–$20.00; today's close sits at 40% of that range, 4.5% below the 52-week high.
Oct 9, 2026 — MMEDV dips 1.0% to $19.50
- Closed at $19.50, -1.02% vs the prior close of $19.70. Day range $19.49–$19.50, opened at $19.49.
- Volume was 300 shares, 0.1x its 50-day average of 2.40K — lighter than usual.
- 52-week range $18.50–$20.00; today's close sits at 67% of that range, 2.5% below the 52-week high.
Oct 8, 2026 — MMEDV rises 2.1% to $19.70
- Closed at $19.70, +2.07% vs the prior close of $19.30. Day range $18.60–$19.70, opened at $18.60.
- Volume was 800 shares, 0.2x its 50-day average of 3.20K — lighter than usual.
- 52-week range $18.50–$20.00; today's close sits at 80% of that range, 1.5% below the 52-week high.
Oct 7, 2026 — MMEDV slides 3.5% to $19.30
- Closed at $19.30, -3.50% vs the prior close of $20.00. Day range $18.50–$19.50, opened at $18.50.
- 52-week range $18.50–$20.00; today's close sits at 53% of that range, 3.5% below the 52-week high.
MMEDV latest news & SEC filings
Every SEC filing by or about MMEDV in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Hopkins Robert (Bob) received an award of 11,877 shares on Oct 15, 2026; now holds 11,877
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Endicott David J. received an award of 3,374 shares on Oct 15, 2026; now holds 15,169
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Bricker Amy received an award of 11,877 shares on Oct 15, 2026; now holds 11,877
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Oct 16, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Oct 16, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Medtronic Plc reported an other transaction of 252,813,348 shares on Oct 15, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.01 — Change in control of the company.
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Oct 13, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Wicks Timothy A received an award of 11,795 shares on Oct 9, 2026; now holds 25,684
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Oct 13, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.07 — Reported shareholder vote results.
Oct 5, 2026 · Form 424B3 — Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade MMEDV
- Last results release: Sep 1, 2026 (8-K Item 2.02). Previous ones: Jun 3, 2026. Based on that rhythm, the next report is likely around Dec 1, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 2.81% (largest 7.7%).
- Liquidity: about 43.73K shares (≈$774.07K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $17.70 vs a range of $15.50–$21.50 (37% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Oct 16, 2026; 8-K Oct 13, 2026; 10-Q Sep 8, 2026.
- Listing: Nasdaq · industry: Surgical & Medical Instruments & Apparatus.
MMEDV market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 18.20 | 18.35 | 17.44 | 17.70 | 226.90K |
| Oct 15, 2026 | 18.50 | 18.57 | 17.20 | 17.50 | 77.80K |
| Oct 14, 2026 | 18.52 | 18.52 | 15.50 | 17.13 | 5.60K |
| Oct 13, 2026 | 21.12 | 21.50 | 18.55 | 18.55 | 12.10K |
| Oct 12, 2026 | 18.50 | 19.43 | 18.50 | 19.10 | 63.70K |
| Oct 9, 2026 | 19.49 | 19.50 | 19.49 | 19.50 | 300 |
| Oct 8, 2026 | 18.60 | 19.70 | 18.60 | 19.70 | 800 |
| Oct 7, 2026 | 18.50 | 19.50 | 18.50 | 19.30 | 6.40K |
| Oct 6, 2026 | 20.00 | 20.00 | 20.00 | 20.00 | 0 |
About MiniMed
MiniMed (MMEDV) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in NORTHRIDGE, CA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 2062583.
MMEDV board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Linnea Burman | Director | Jul 6, 2026 |
| Scott T Cundy | Director | Jul 6, 2026 |
| Que Dallara | Chief Executive Officer | Aug 4, 2026 |
| Glenn A Eisenberg | Director | Mar 11, 2026 |
| David J. Endicott | Director | Jul 6, 2026 |
| D Keith Grossman | Director | Mar 11, 2026 |
| Robert (Bob) Hopkins | Director | Mar 6, 2026 |
| Kevin E Lofton | Director | Mar 11, 2026 |
| Laura Mauri | Director | Mar 6, 2026 |
| Brian Sandstrom | Director | Mar 5, 2026 |
| Brett A. Wall | Director | Mar 6, 2026 |
| Matthew R. Walter | Director | Mar 6, 2026 |
| Timothy A Wicks | Director | Mar 11, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Gillian Chandrasena | SVP, Chief HR Officer | Jul 29, 2026 |
| Que Dallara | Chief Executive Officer | Aug 4, 2026 |
| Ali Dianaty | EVP Ch. Prod. & Tech Officer | Aug 4, 2026 |
| Christopher Eso | President | Mar 5, 2026 |
| John Gyurci | VP, Chief Accounting Officer | Jul 6, 2026 |
| Chad Spooner | EVP, Chief Financial Officer | Jul 29, 2026 |
| Courtney Nelson Wills | SVP, Gen. Counsel, Corp. Sec. | Aug 4, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
MMEDV financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Apr 24, 2026 | $3.10B | $-333.00M | -1.30 | $-197.00M |
| Apr 25, 2025 | $2.71B | $-213.00M | -0.84 | $140.00M |
| Apr 26, 2024 | $2.47B | $-112.00M | -0.44 | $41.00M |
Latest balance sheet: total assets $4.72B, total liabilities $1.10B, cash $207.00M (as of Jul 31, 2026).
MMEDV earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Sep 1, 2026 | 8-K Item 2.02 (results) | — |
| Jun 3, 2026 | 8-K Item 2.02 (results) | — |
Related stocks · Surgical & Medical Instruments & Apparatus
Boston Scientific (BSX)Stryker (SYK)3M (MMM)Dexcom (DXCM)Medline (MDLN)Becton Dickinson (BDX)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)Glaukos (GKOS)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on MMEDV
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.